FDA Inspection 1246877 — Gulf Coast Regional Blood Center at Westchase

Gulf Coast Regional Blood Center at Westchase — FEI 3006799214

The FDA completed an inspection of Gulf Coast Regional Blood Center at Westchase on September 12, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)